1. Zambrano LD, Ellington S, Strid P, et al. Update: Characteristics of symptomatic women of childbearing age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status — United States, January 22 to October 3, 2020. MMWR Morb Mortal Wkly Rep 2020;69:1641–1647.
2. abstain CL, Wallace B., Simeone RM, et al. Risk of stillbirth among women with and without COVID-19 during childbirth hospitalization – United States, March 2020 to September 2021. MMWR Morb Mortal Wkly Rep 2021;70:1640–1645.
3. AA buttocks, Chemaitelly H, Al-Khal A, et al. Efficacy of SARS-CoV-2 vaccine in preventing confirmed infection in pregnant women. J Clin Invest 2021;131(23):e153662–e153662.
4. Dagan N., Barda N., Biron Shental T, et al. Efficacy of the BNT162b2 mRNA COVID-19 vaccine during pregnancy. NatMed 2021;27:1693–1695
5. Lipkind HS, Vazquez-Benitez G, De Silva M., et al. Receiving COVID-19 Vaccine During Pregnancy and Prematurity or Small-for-Gestational Age at Birth – Eight Integrated Health Care Organizations, United States, December 15, 2020-July 22, 2021. MMWR Morb Mortal Wkly Rep 2022;71:26–30.
6. Shimabukuro TT, Kim SY, Myers TR, et al. Preliminary results of the safety of the Covid-19 mRNA vaccine in pregnant women. N English J med 2021;384:2273–2282.
seven. Zauche LH, Wallace B., Smoots AN, et al. Reception of Covid-19 mRNA vaccines and risk of spontaneous abortion. N English J med 2021;385:1533–1535.
8. Magnus MC, Gjessing HK, Eide HN, Wilcox AJ, Fell DB, Haberg SE. Covid-19 Vaccination during pregnancy and first trimester miscarriage. N English J med 2021;385:2008–2010.
9. Centers for Control and Prevention of Disasters. COVID-19 vaccines during pregnancy or breastfeeding (https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/pregnancy.html).
ten. Abu Raya B, Edwards KM, Scheifele DW, Halperin S.A.. Whooping cough and influenza vaccination during pregnancy: a review of the landscape. Lancet Infect Dis 2017;17(7):e209–e222.
11. Azziz-Baumgartner E, Grohskopf L, Patel M. Realizing the potential of maternal influenza vaccination. JAMA 2021;325:2257–2259.
12. Omer SB. Maternal immunization. N English J med 2017;376:1256–1267.
13. Halasa NB, Olson SM, MA state, et al. Effectiveness of Maternal Immunization with COVID-19 mRNA Vaccine During Pregnancy Against COVID-19 Associated Hospitalization in Infants <6 Months of Age - 17 States, July 2021-January 2022. MMWR Morb Mortal Wkly Rep 2022;71:264–270.
14. Carlsen EE, Magnus MC, Oakley L, et al. Association of COVID-19 vaccination during pregnancy with the incidence of SARS-CoV-2 infection in infants. JAMA Medical Intern 2022 June 1 (Epub ahead of print).
15. Mithal LB, Otero S, Shane ED, Goldstein JA, Miller ES. Cord blood antibodies following maternal vaccination against coronavirus disease 2019 during pregnancy. Am J Obstet Gynecol 2021;225:192–194.
16. Beharier O, Plitman Mayo R, Once T., et al. Efficient maternal-to-newborn transfer of SARS-CoV-2 vaccine antibodies and BNT162b2 COVID-19 mRNA. J Clin Invest 2021;131:150319–150319.
17. Prabhu M, Murphy E.A., Sukhu AC, et al. Antibody response to messenger RNA vaccination of coronavirus disease 2019 (COVID-19) in pregnant women and transplacental passage in cord blood. Obstet Gynecol 2021;138:278–280.
18. pearl SH, Uzan-Yulzari A, Klainer H, et al. SARS-CoV-2 specific antibodies in breast milk after COVID-19 vaccination of breastfeeding women. JAMA 2021;325:2013–2014.
19. JK Baird, Jensen SM, Urba WJ, Fox BA, Baird JR. SARS-CoV-2 antibodies detected in breast milk after vaccination. J Hum Lact 2021;37:492–498.
20. Yang YJ |, Murphy E.A., Singh S, et al. Association of gestational age with vaccination against coronavirus disease 2019 (COVID-19), history of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and a booster dose of vaccine with maternal and umbilical cord antibody levels at delivery. Obstet Gynecol 2022;139:373–380.
21. sidewalk me, Aguero-Rosenfeld ME, Roman AS, JL lighter. High levels of antibodies in the cord blood of pregnant women vaccinated against COVID-19. Am J Obstet Gynecol MFM 2021;3:100481–100481.
22. Nir O, Schwartz A., Toussia Cohen S, et al. Maternal-neonatal transfer of SARS-CoV-2 immunoglobulin G antibodies in parturient women treated with the BNT162b2 messenger RNA vaccine during pregnancy. Am J Obstet Gynecol MFM 2022;4:100492–100492.
23. shook LL, Atyeo CG, Yonker LM, et al. Durability of anti-spike antibodies in infants following maternal COVID-19 vaccination or natural infection. JAMA 2022;327:1087–1089.
24. KJ Brands, Whitaker M, Agathis NT, et al. Hospitalization of infants and children 0-4 years old with laboratory confirmed COVID-19 – COVID-NET, 14 States, March 2020 to February 2022. MMWR Morb Mortal Wkly Rep 2022;71:429–436.
25. Hobbs Resume, Woodworth K, Young CC, et al. Frequency, characteristics and complications of COVID-19 in hospitalized infants. Infect Pediatrician Say J 2022;41(3):e81–e86.
26. Mølgaard-Nielsen D, Fischer TK, Krause TG, Hvid A. Effectiveness of maternal immunization with inactivated trivalent influenza vaccine in pregnant women and their infants. J Internal Med 2019;286:469–480.
27. Olson SM, Newhams MM, Halasa NB, et al. Efficacy of the potentially fatal flu vaccine in American children. Blink Infect Dis 2022 January 13 (Epub ahead of print).
28. acid friends, Feng S, Lewnard JA, et al. The use of test-negative controls to monitor vaccine efficacy: a systematic review of methodology. Epidemiology 2020;31:43–64.
29. Olson SM, Newhams MM, Halasa NB, et al. Efficacy of the BNT162b2 vaccine against Critical Covid-19 in adolescents. N English J med 2022;386:713–723.
30. Olson SM, Newhams MM, Halasa NB, et al. Efficacy of Pfizer-BioNTech mRNA Vaccination Against COVID-19 Hospitalization in People Aged 12-18 Years – United States, June-September 2021. MMWR Morb Mortal Wkly Rep 2021;70:1483–1488.
31. Federal Registry Office. Code of Federal Regulations: a one-time eCFR system. Title 45 (https://www.ecfr.gov/cgi-bin/text-idx?SID=fc043bd2812f0775fa80066558a6bbcf&mc=true&node=pt45.1.46&rgn=div5#se45.1.46_1102).
32. Razzaghi H, Megani M, Pingali C, et al. COVID-19 vaccination coverage in pregnant women during pregnancy – eight integrated health care organizations, United States, December 14, 2020-May 8, 2021. MMWR Morb Mortal Wkly Rep 2021;70:895–899.
33. Patel MK, Bergeri I, Bresee JS, et al. Evaluation of post-introduction COVID-19 vaccine efficacy: summary of interim guidance from the World Health Organization. Vaccine 2021;39:4013–4024.
34. Centers for Control and Prevention of Disasters. COVID data tracker: variable proportions (https://covid.cdc.gov/covid-data-tracker/#variant-proportions).
35. KJ gray, Bordt EA, Atyeo C, et al. Vaccine response against coronavirus disease 2019 in pregnant and lactating women: a cohort study. Am J Obstet Gynecol 2021;225(3):303.e1–303.e17.
36. PN Klein, Stockwell SP, Demarco M, et al. Efficacy of Pfizer-BioNTech BNT162b2 COVID-19 mRNA Vaccination in Preventing Emergency and Urgent Care Visits and Hospitalizations Associated with COVID-19 in Non-Immunocompromised Children and Adolescents Aged 5-17 Years – VISION Network , 10 States, April 2021-January 2022. MMWR Morb Mortal Wkly Rep 2022;71:352–358.
37. Laura AS, Tenford MW, JD Chappell, et al. Clinical severity and efficacy of mRNA vaccines against Covid-19 from omicron, delta and alpha variants of SARS-CoV-2 in the United States: prospective observational study. BMJ 2022;376:e069761–e069761.
38. Centers for Control and Prevention of Disasters. Cumulative data on file: Percentage of pregnant women ages 18-49 receiving at least one dose of a COVID-19 vaccine during pregnancy, by race/ethnicity and date of notification to CDC-Vaccine Safety Datalink*, United States | December 20, 2020–January 20, 2022 (https://data.cdc.gov/Vaccinations/Cumulative-Data-Percent-of-Pregnant-People-aged-18/4ht3-nbmd/data).
39. Nemet I, L-clicker, Funny Y, et al. Third neutralization by BNT162b2 vaccination of SARS-CoV-2 omicron infection. N English J med 2022;386:492–494.
40. Thompson MG, Natarajan K, Irving SA, et al. Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19 Associated Emergency and Urgent Care Visits and Adult Hospitalizations During Periods of Delta and Omicron Variant Prevalence – VISION Network, 10 States, August 2021-January 2022. MMWR Morb Mortal Wkly Rep 2022;71:139–145.